DaVita stock kpis
Want to see DVA full AI Analyst Report?
Average Treatments per Day
DaVita reported average treatments per day of 92,780 in Q3 2026, up 0.1% from Q2 2026 and up 1.2% year over year. The highest value was 97,063 in Q2 2020.
Measures the average number of treatments conducted daily, offering insight into operational efficiency and patient demand.
Average treatments per day have moved down from 2020 peaks and essentially flattened since, with a modest mid‑2026 uptick that matches management’s claim of accelerating treatment growth and guidance near the top of its prior 25–50 bps range (longer‑term 2% target). Stabilizing volumes should support scale, but persistent revenue‑per‑treatment pressure, ACA commercial mix headwinds and elevated patient‑care cost trends mean treatment gains alone may not translate to sustained margin expansion without continued operational execution.
DVA Average Treatments per Day
| Period | Average Treatments per Day |
|---|---|
| Q3 2026Sep 30, 2026 | 92,780 |
| Q2 2026Jun 30, 2026 | 92,649 |
| Q1 2026Mar 31, 2026 | 91,650 |
| Q4 2025Dec 31, 2025 | 91,608 |
| Q3 2025Sep 30, 2025 | 91,680 |
| Q2 2025Jun 30, 2025 | 92,131 |
| Q1 2025Mar 31, 2025 | 91,793 |
| Q4 2024Dec 31, 2024 | 92,534 |
| Q3 2024Sep 30, 2024 | 93,048 |
| Q2 2024Jun 30, 2024 | 93,147 |
| Q1 2024Mar 31, 2024 | 92,159 |
| Q4 2023Dec 31, 2023 | 92,542 |
| Q3 2023Sep 30, 2023 | 92,493 |
| Q2 2023Jun 30, 2023 | 92,708 |
| Q1 2023Mar 31, 2023 | 92,434 |
| Q4 2022Dec 31, 2022 | 92,506 |
| Q3 2022Sep 30, 2022 | 92,859 |
| Q2 2022Jun 30, 2022 | 93,194 |
| Q1 2022Mar 31, 2022 | 92,335 |
| Q4 2021Dec 31, 2021 | 94,640 |
| Q3 2021Sep 30, 2021 | 94,509 |
| Q2 2021Jun 30, 2021 | 95,045 |
| Q1 2021Mar 31, 2021 | 94,636 |
| Q4 2020Dec 31, 2020 | 96,667 |
| Q3 2020Sep 30, 2020 | 96,914 |
| Q2 2020Jun 30, 2020 | 97,063 |
| Q1 2020Mar 31, 2020 | 96,821 |

